

Listening to the people at the heart of healthcare
At GE HealthCare, we see possibilities through innovation. As a stand-alone company, GE HealthCare is a leader in precision care, infusing innovation with patient-focused technologies to enable better care. We’re dedicated to providing integrated solutions that make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier. Together, we’re living our purpose to create a world where healthcare has no limits.

Cerianna: Advancing Estrogen Receptor Targeted PET-CT for Breast Cancer Diagnosis and Beyond
Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]

Fluorinated Estradiol Imaging with Cerianna PET CT: Enhancing Assessment of Estrogen Receptor Positive Breast Cancer
Dr. Robert Bridwell, MD, Co-Founder, Chief Medical Officer, and Head Clinical Architect at Appian 360 introduced fluorinated estradiol imaging for PET CT technology and discussed its use in breast cancer patients with estrogen receptor-positive tumors. He explained that the technology allows for a more comprehensive assessment of the biology across multiple metastatic lesions, rather […]

DaTscan: Advancing Parkinsonian Syndrome Diagnosis and Safety Precautions
DaTscan is a radiopharmaceutical instrument for assessing adults suspected of Parkinsonian syndrome (PS). Phillip Kuo MD, PhD and Scott Sherman, MD, Phd sheds some light on this tool. DaTscan is proficient in distinguishing essential tremors from those induced by PS, including idiopathic Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). […]
